The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Share
More article options
Full text access
How do the different hemoglobin therapeutic targets affect the mortality and cardiovascular events when managing anemia with different erythropoiesis-stimulating agents in chronic renal failure?
En el tratamiento de la anemia de la insuficiencia renal crónica con agentes estimulantes de la eritropoyesis, ¿cómo afectan distintas dianas terapéuticas de hemoglobina a la mortalidad y a sucesos cardiovasculares?
Visits
3673
F. García López
This item has received
Article information




